Search - tctmd.com

Displaying 81 - 100 of 172

Sort: Relevancy | Date

GRACE Risk Tool Fails to Increase Use of Guideline-Based Care After ACS: AGRIS

News Conference News ESC 2019

GRACE Risk Tool Fails to Increase Use of Guideline-Based Care After ACS: AGRIS

Yael L. Maxwell

September 10, 2019

Updated EAS/ESC Dyslipidemia Guidelines Lower LDL Targets, Broaden Risk Categories

News Conference News ESC 2019

Updated EAS/ESC Dyslipidemia Guidelines Lower LDL Targets, Broaden Risk Categories

Yael L. Maxwell

September 06, 2019

Transfer for Primary PCI Still Better Than Fibrinolysis After 16 Years: DANAMI-2

News Conference News ESC 2019

Transfer for Primary PCI Still Better Than Fibrinolysis After 16 Years: DANAMI-2

September 04, 2019

Ruling Out MI Safe With 0/1-Hour High-Sensitivity Troponin: RAPID-TNT

News Conference News ESC 2019

Ruling Out MI Safe With 0/1-Hour High-Sensitivity Troponin: RAPID-TNT

Michael O'Riordan

September 03, 2019

COMPLETE Beats Culprit-Only PCI in Multivessel STEMI and Timing Doesn’t Matter

News Conference News ESC 2019

COMPLETE Beats Culprit-Only PCI in Multivessel STEMI and Timing Doesn’t Matter

Yael L. Maxwell

September 01, 2019

Radial PCI Up, but Vascular Complication Rates Haven’t Budged

News Daily News

Radial PCI Up, but Vascular Complication Rates Haven’t Budged

Yael L. Maxwell

August 29, 2019

Decline in US Deaths From CVD and Diabetes Is Leveling Off

News Daily News

Decline in US Deaths From CVD and Diabetes Is Leveling Off

August 27, 2019

Learning Curve for New CTO Operators: Some Reassurances, Some Caveats

News Daily News

Learning Curve for New CTO Operators: Some Reassurances, Some Caveats

August 26, 2019

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

News Daily News

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

Michael O'Riordan

August 26, 2019

#Selfies, Carrots, and Push-ups: A Defense of Social Media in Modern-Day Medicine

News Opinion Off Script

#Selfies, Carrots, and Push-ups: A Defense of Social Media in Modern-Day Medicine

Mamas Mamas, BMBCh

August 23, 2019

PolyIran: Polypill Prevents Major Cardiovascular Events Over 5 Years

News Daily News

PolyIran: Polypill Prevents Major Cardiovascular Events Over 5 Years

August 23, 2019

No Volume-Outcome Link With Watchman for LAA Closure? Single-Center Study

News Daily News

No Volume-Outcome Link With Watchman for LAA Closure? Single-Center Study

Michael O'Riordan

August 19, 2019

FDA Expands TAVR Indication to Low-Risk Patients

News Daily News

FDA Expands TAVR Indication to Low-Risk Patients

Michael O'Riordan

August 16, 2019

AHA Outlines Diagnosis, Treatment Options for Underrecognized Critical Limb Ischemia

News Daily News

AHA Outlines Diagnosis, Treatment Options for Underrecognized Critical Limb Ischemia

August 12, 2019

In Carotid RCTs, Outcomes Improved Over Time for CEA but not CAS: Meta-analysis

News Daily News

In Carotid RCTs, Outcomes Improved Over Time for CEA but not CAS: Meta-analysis

August 09, 2019

Same-Day Discharge After PCI Just as Safe as Overnight Stay, UK Study Finds

News Daily News

Same-Day Discharge After PCI Just as Safe as Overnight Stay, UK Study Finds

Marcus A. Banks

August 06, 2019

Pursuing Training in Structural Heart Interventions: Q&A With Mario Gössl, MD

News Opinion Fellow Talk

Pursuing Training in Structural Heart Interventions: Q&A With Mario Gössl, MD

Yashasvi Chugh, MD

August 05, 2019

Stroke After PCI: Rare but Rising as Patient Complexity Climbs

News Daily News

Stroke After PCI: Rare but Rising as Patient Complexity Climbs

August 05, 2019

Managing Coronary Artery Dissection with No Wire Access

Presentation CHIP Seattle 2019

Managing Coronary Artery Dissection with No Wire Access

Presenter: Robert F. Riley

August 02, 2019

TCTMD’s Top 10 Most Popular Stories for July 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for July 2019

July 31, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.